A detailed history of Btg Pactual Global Asset Management LTD transactions in Axonics, Inc. stock. As of the latest transaction made, Btg Pactual Global Asset Management LTD holds 10,000 shares of AXNX stock, worth $709,800. This represents 0.11% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$709,800
% of portfolio
0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $566,700 - $693,600
10,000 New
10,000 $689,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Btg Pactual Global Asset Management LTD Portfolio

Follow Btg Pactual Global Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.